Merger Update

Smith & Nephew Plc 13 March 2002 13 March 2002 ANTITRUST WAITING PERIOD ENDS FOR ORATEC TENDER OFFER Smith & Nephew plc, the global advanced medical devices group, today announced that the Hart-Scott-Rodino waiting period applicable to Smith & Nephew's tender offer for all outstanding shares of common stock of ORATEC Interventions, Inc. (NASDAQ: OTEC) has expired. The tender offer is being made pursuant to an agreement and plan of merger dated 13 February 2002. The tender offer will expire at 12:00 Midnight, New York City time, on Thursday, 21 March 2002, unless the offer is extended. U.S. Bancorp Piper Jaffray is the dealer manager for the tender offer, American Stock Transfer & Trust Company is the depositary and Morrow & Co., Inc. is the information agent. Enquiries: Morrow & Co., Inc. Information Agents Banks & Brokers: In US - (800) 654-2468 Outside US - (212) 754-8000 Stockholders: In US - (800) 607-0088 Outside US - (212) 754-8000 e-mail: ORATEC.info@morrowco.com About Smith & Nephew Smith & Nephew plc, (London Stock Exchange: SN), (NYSE: SNN), is a global advanced medical devices company with a highly successful track record in developing, manufacturing and marketing a wide variety of innovative and technologically advanced tissue repair products. These products are primarily in the areas of bone, joints, skin and other soft tissue. Smith & Nephew have extensive marketing and distribution capabilities, with established sales in more than 90 countries. For further information, visit Smith & Nephew's Web site at www.smith-nephew.com. Smith & Nephew Endoscopy (www.endoscopy1.com) is one of its major businesses, and is a world leader in the development and commercialisation of endoscopic techniques. Within endoscopy, Smith & Nephew is the recognised world leader in arthroscopy (endoscopic procedures performed on articulating joints). This information is provided by RNS The company news service from the London Stock Exchange
UK 100